Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

Dr Jose Lopez-Sendon

José López-Sendón

Director, Cardiology Department

Hospital Universitario La Paz, IdiPaz, Madrid, Spain

Expertise

Anticoagulation Electrophysiology & Arrhythmia Atrial Fibrillation Angina Prevention & Chronic Conditions Coronary Artery Disease and Myocardial Infarction Intervention

Biography

Chief Cardiologist, Hospital University La Paz, Madrid, Spain

Media

Broadcast

Electrophysiology & Arrhythmia

Intervention

Utilizing NOAC's in Non-Valvular Atrial Fibrillation Patients Undergoing…

Robert A Byrne, Georg Nickenig, Stefan H Hohnloser, et al

Watch time: 30m 6s

NOACs in non-valvular atrial fibrillation patients undergoing PCI - SPANISH

Video

Anticoagulation

Electrophysiology & Arrhythmia

Utilizing NOACs in NVAF patients undergoing PCI

José López-Sendón, Jose Luis Zamorano

Watch time: 20m 37s

Articles by José López-Sendón, Director, Cardiology Department

ISCHEMIA Trial: Key Questions and Answers

José López-Sendón, Raul Moreno, Juan Tamargo, et al

Published: 14 September 2021

Citation: European Cardiology Review 2021;16:e34.

DOI:

https://doi.org/10.15420/ecr.2021.16

New Drugs for Thromboembolic Prevention in Atrial Fibrillation

Jose L Merino, José López-Sendón,

Citation: European Cardiology 2010;6(4):64–9

DOI:

https://doi.org/10.15420/ecr.2010.6.4.64